Perioperative management of cardiac surgery patient with immune thrombocytopenic purpura (ITP)
Location
Auditorium Pond Side
Start Date
26-2-2014 10:30 AM
Abstract
We report a case of 58-year-old male patient with immune thrombocytopenic purpura (ITP) who underwent coronary artery bypass grafting (CABG) and aortic valve replacement (AVR) surgery. Cardiac surgery itself is known to be associated with increased risk of bleeding and higher requirements for transfusion. Bleeding risk is increased further in patients who suffered from ITP. We use steroids, tranexamic acid (TXA) combined with platelet, and FFPs transfusion in the operating room to reduce bleeding complications for a patient with ITP. Multidisciplinary team of anaesthetist, surgeon, haematologist and intensivist were involved during successful perioperative management of this patient.
Keywords: coronary artery bypass grafting, Aortic Valve replacement, Immune thrombocytopenic purpura, Cardiac surgery
Perioperative management of cardiac surgery patient with immune thrombocytopenic purpura (ITP)
Auditorium Pond Side
We report a case of 58-year-old male patient with immune thrombocytopenic purpura (ITP) who underwent coronary artery bypass grafting (CABG) and aortic valve replacement (AVR) surgery. Cardiac surgery itself is known to be associated with increased risk of bleeding and higher requirements for transfusion. Bleeding risk is increased further in patients who suffered from ITP. We use steroids, tranexamic acid (TXA) combined with platelet, and FFPs transfusion in the operating room to reduce bleeding complications for a patient with ITP. Multidisciplinary team of anaesthetist, surgeon, haematologist and intensivist were involved during successful perioperative management of this patient.
Keywords: coronary artery bypass grafting, Aortic Valve replacement, Immune thrombocytopenic purpura, Cardiac surgery